Value of treatment, risk and responsibility in urological practice

1. Briefing note for OECD health data 2010: how does the Czech Republic compare. 29 June 2010. Orga­nisation for Economic Co-operation and De­ve­lop­ment. 16 April 2011 <http://www.oecd.org/dataoecd/ /42/43/40904906.pdf>.

2. Guidelines on urological infections. April 2010. European Association of Urology. 16 April 2011 <http://www.uroweb.org/gls/pdf/Urological%20Infec-tions%202010.pdf>.

3. Wolf JS Jr., Bennett CJ, Dmochowski RR et al. Best practice policy statement on urologic surgery antimic­ro­bial prophylaxis. J Urol 2008; 179(4): 1379–1390.

4. Rotjanapan P, Dosa D, Thomas KS. Potentially inappropriate treatment of urinary tract infections in two Rhode Island nursing homes. Arch Intern Med 2011; 171(5): 438–443.

5. Batura D, Rao GG, Nielsen PB. Prevalence of anti­microbial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy. BJU Int 2010; 106(7): 1017–1020.

6. Neulander EZ, Yusim I, Kaneti J. Re: increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy:

R. K. Nam, R. Saskin, Y. Lee et al. J Urol 2010; 183: 963–969. J Urol 2010; 184(5): 2216–2217.

7. Park DS, Oh JJ, Lee JH et al. Simple use of the suppository type povidone-iodine can prevent infectious complications in transrectal ultrasound-guided prostate biopsy. Adv Urol 2009: 750598.

8. Saylor PJ, Smith MR. Metabolic complications of androgen deprivation therapy for prostate cancer. J Urol 2009; 181(5): 1998–2006.

9. Porter ME. What is value in health care? NEJM 2010; 363(26): 2477–2481.

10. Flanigan RC, Polcari AJ, Hugen CM. Prognostic

variables and nomograms for renal cell carcinoma. Int J Urol 2011; 18(1): 20–31.

11. Drazer MW, Huo D, Schonberg MA et al. Popu­lation-based patterns and predictors of prostate-specific antigen screening among older men in the United States. J Clin Oncol 2011; 29(13): 1736–1743.

12. Walter LC, Bertenthal D, Lindquist K et al. PSA screening among elderly men with limited life expectancies. JAMA 2006; 296(19): 2336–2342.

13. Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 2003; 289 (11):1414–1420.